Spots Global Cancer Trial Database for Evaluation of Study Experiences of Neuroendocrine Tumor Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Evaluation of Study Experiences of Neuroendocrine Tumor Patients
Official Title: Investigating the Clinical Trial Journey and Engagement of Neuroendocrine Tumor Patients
Study ID: NCT05967481
Conditions
Interventions
Study Description
Brief Summary: Taking part in clinical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This research will admit a wide range of data on the clinical study experience of neuroendocrine tumor patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future patients with neuroendocrine tumor.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Power Life Sciences, San Francisco, California, United States
Contact Details
Name: Michael B Gill
Affiliation: Power Life Sciences Inc.
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
